To accompany the upcoming EUnetHTA 2019 Assembly & Forum 0n 10-11th April in Amsterdam, a Welcome Guide has been developed to give participants and attendees a thorough overview of the event proceedings, practical information, and EUnetHTA's working activities. The guide is
EUnetHTA recently started a new Joint Assessment on a medicinal product for secondary progressive MS. To find out about participation, please read more here. Input submissions will be received through till EOB, April 28th.
The day's agenda is now available for the upcoming 2019 EUnetHTA Forum on 11th April at the West-Indisch Huis in central Amsterdam. We are looking forward to hosting a collaborative, informative session of talks that both outline progress made in European
Assessment Publication: Jointly Produced HTA Report; Partner Profile: Austria; Impact: Austria; Partner Profile: UK; Innovation & HTA: Giovanni Tafuri; Prioritisation List: Topics & Joint Assessments; 2018: Year in Review Download your copy HERE.
EUnetHTA recently started a new Joint Assessment on a medicinal product for the treatment of adult patients with moderately to severely active ulcerative colitis (UC), who have had an inadequate response with. lost response to, or were intolerant to either
EUnetHTA recently started a new Joint Assessment on a medicinal product for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not candidates for hematopoietic stem cell transplant. To find out more about how patient
EUnetHTA publishes the EUnetHTA Prioritisation List (EPL) Find the EPL HERE The EPL expresses the identified significant interest of national HTA bodies in relation to individual compounds as presented in the list. By pro-actively selecting those topics in direct collaboration with national
HTA proposal: update; HTA reports; Impact: Italy; Interview: EP Rapporteur: Soledad Cabezón Ruiz MEP; Partner Profile: AIFA; Senior Science Officer: Giovanni Tafuri; working together: HTA Network Stakeholder Pool Downloadable PDF HERE [pdf-embedder url="https://www.eunethta.eu/wp-content/uploads/2018/10/Fall_2018_Magazine-2.pdf" title="Fall_2018_Magazine (2)"]
"HTA cooperation produces and will produce very tangible benefits not only for patients, but also improve the quality and sustainability of health systems when Europe needs them most." [vc_row][vc_column][vc_single_image image="15600" img_size="large"][vc_column_text] [pdf-embedder url="https://www.eunethta.eu/wp-content/uploads/2018/09/Summer_2018_Magazine-2-Photos-Sidebar-and-1-Column.pdf" title="Summer_2018_Magazine - 2 Photos, Sidebar, and 1 Column"][/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row]